Precision disease management: prognostic biomarker for chronic lung damage in long COVID
Early detection of potential severe disease progression facilitates implementation of relevant precise disease management strategies. MMP-7 is a reliable prognostic biomarker for long COVID persistent lung damage that should be considered for clinical use. https://bit.ly/3Ccxozg.Early detection of p...
Uloženo v:
| Vydáno v: | ERJ open research Ročník 10; číslo 6; s. 647 |
|---|---|
| Hlavní autoři: | , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
England
European Respiratory Society
01.11.2024
|
| ISSN: | 2312-0541, 2312-0541 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Shrnutí: | Early detection of potential severe disease progression facilitates implementation of relevant precise disease management strategies. MMP-7 is a reliable prognostic biomarker for long COVID persistent lung damage that should be considered for clinical use. https://bit.ly/3Ccxozg.Early detection of potential severe disease progression facilitates implementation of relevant precise disease management strategies. MMP-7 is a reliable prognostic biomarker for long COVID persistent lung damage that should be considered for clinical use. https://bit.ly/3Ccxozg. |
|---|---|
| Bibliografie: | SourceType-Scholarly Journals-1 content type line 23 ObjectType-Editorial-2 ObjectType-Commentary-1 |
| ISSN: | 2312-0541 2312-0541 |
| DOI: | 10.1183/23120541.00647-2024 |